Mr. Casdin
a member of the Board
$5.0 million
December 9, 2025
Company invested $5.0 million in unsecured convertible loan notes of a privately-held life sciences company, alongside a fund associated with Mr. Casdin.
With a privately-held life sciences company
Open in proxy